Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.59 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.50 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | GABRR1 | P24046 | 1/20 | 0.50 |
| ▸ | GABRR2 | P28476 | 1/20 | 0.50 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.50 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.50 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.50 |
| ▸ | HRH4 | Q9H3N8 | 3/20 | 0.49 |
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | GLA | P06280 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17308657 | 1.00 | CYP3A4 (0.59) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL26315497 | 0.86 | SLC22A4 (0.55) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL1331027 | 0.86 | SLC22A4 (0.55) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL26315500 | 0.83 | CYP3A4 (0.48) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL791747 | 0.78 | CYP3A4 (0.65) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL14411160 | 0.78 | CYP3A4 (0.65) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL27972810 | 0.77 | ITGB2 (0.56) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL1624184 | 0.76 | CYP3A4 (0.67) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL29385058 | 0.76 | CYP3A4 (0.67) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 | |
| SCHEMBL1131474 | 0.76 | CYP3A4 (0.67) | CYP3A4SLC7A5CPB2ALDH1A1NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026097644-A1 | ACTIVE PREVENTION AND CONTROL METHOD FOR INOCULATION PROCESS OF FRACTURE-TYPE ROCK BURST IN DEEP-BURIED TUNNEL | 东北大学 | 2026-05-15 | — | — | WO | disclosed |
| US-11767756-B2 | Method and system for the determination of hydrocarbon accumulations | ABU DHABI NATIONAL OIL COMPANY (AE) | 2023-09-26 | — | — | US | disclosed |
| WO-2022220263-A1 | ERGOTHIONEINE PRODUCTION METHOD | 大学共同利用機関法人情報・システム研究機構 | 2022-10-20 | — | — | WO | disclosed |
| WO-2022185873-A1 | ERGOTHIONEINE PRODUCTION METHOD | 長瀬産業株式会社 | 2022-09-09 | — | — | WO | disclosed |
| WO-2022185872-A1 | ERGOTHIONEINE PRODUCTION METHOD | 長瀬産業株式会社 | 2022-09-09 | — | — | WO | disclosed |
| CN-114779363-A | Method and system for determining hydrocarbon deposits | 阿布扎比国家石油公司 | 2022-07-22 | — | — | CN | disclosed |
| US-20220195870-A1 | METHOD AND SYSTEM FOR THE DETERMINATION OF HYDROCARBON ACCUMULATIONS | ABU DHABI NATIONAL OIL COMPANY (AE) | 2022-06-23 | — | — | US | disclosed |
| EP-4016136-A1 | METHOD AND SYSTEM FOR THE DETERMINATION OF HYDROCARBON ACCUMULATIONS | Abu Dhabi National Oil Company (AE) | 2022-06-22 | — | — | EP | disclosed |
| US-11353621-B2 | Method and alarming system for CO2 sequestration | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2022-06-07 | — | — | US | disclosed |
| US-20170283382-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | TETRAHEDRON (FR) | 2017-10-05 | — | — | US | disclosed |
| US-20170283382-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | TETRAHEDRON (FR) | 2017-10-05 | — | — | US | disclosed |
| WO-2016042273-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | TETRAHEDRON (FR) | 2016-03-24 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170283382-A1 | METHOD FOR PRODUCING PURE L-HERCYNINE | MLX, MLEC, PTMS | CYP3A4 3127/4885SLC7A5 284/4885CPB2 1696/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.